Authors:
Bier, H
Hoffmann, T
Hauser, U
Wink, M
Ochler, M
Kovar, A
Muser, M
Knecht, R
Citation: H. Bier et al., Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx, CANC CHEMOT, 47(6), 2001, pp. 519-524
Authors:
Kiefer, J
von Ilberg, C
Rupprecht, V
Hubner-Egner, J
Knecht, R
Citation: J. Kiefer et al., Optimized speech understanding with the continuous interleaved sampling speech coding strategy in patients with cochlear implants: Effect of variations in stimulation rate and number of channels, ANN OTOL RH, 109(11), 2000, pp. 1009-1020
Authors:
Knecht, R
Elez, R
Oechler, M
Solbach, C
von Ilberg, C
Strebhardt, K
Citation: R. Knecht et al., Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck, CANCER RES, 59(12), 1999, pp. 2794-2797
Citation: R. Knecht, Immunological tumour parameters in squamous cell carcinomas of the upper aerodigestive tract, LARY RH OTO, 77(11), 1998, pp. 624-626
Authors:
Kiefer, J
von Ilberg, C
Reimer, B
Knecht, R
Gall, V
Diller, G
Sturzebecher, E
Pfennigdorff, T
Spelsberg, A
Citation: J. Kiefer et al., Results of cochlear implantation in patients with severe to profound hearing loss - Implications for patient selection, AUDIOLOGY, 37(6), 1998, pp. 382-395